Alicia Dorner is a strategic advisor to private and public companies across a broad range of corporate matters, including mergers and acquisitions, venture and growth equity financings, joint ventures, and other complex transactions. She is a partner with the firm, serving as a member of the Venture & Growth Capital and Emerging Company Practices, and is also a member of the firm’s Innovative Technology and Health Care & Life Sciences Sectors. She also serves as the firm’s Boston Chapter Women’s Network Representative.
Alicia has a significant background advising emerging companies throughout their lifecycles on fundraising transactions, strategic partnerships, reorganizations, and sale transactions. She regularly acts as general outside counsel for private and venture-backed companies, providing guidance on corporate structure, governance, and transactional matters. Her extensive experience also includes representing venture capital funds, corporate venture capital investors, private equity funds and family offices that invest in technology, health care, life sciences, and other innovative industries.
Representative Experience
- Represented a clinical trials support and logistics company in its sale to a private equity buyer (2026).
- Represented a corporate venture capital investor in its investments across dozens of digital health and innovative technology companies totaling more than US$200M of new investment (2025, 2026)
- Represented an agricultural technology company in its Series Seed, Series A and Series B fundraising rounds (2023, 2024, 2025, 2026).
- Represented a SaaS company in the healthcare technology industry as general outside counsel in its formation and growth (2025, 2026).
- Represented Capital Rx in a US$400M Series F financing (2025).
- Represented a venture capital investor in a US$33M Series B extension financing for Phoenix Tailings, Inc., a developer of rare earths from mining waste. (2025)
- Represented a healthcare company specializing in equilibrium and balance conditions in its sale to a private equity buyer (2024).
- Represented a comprehensive oncology and hematology practice in its sale to a private equity buyer (2024).
- Represented NEA as lead investor in a US$12m Series A financing for Fizz, a college social media app (2024).
- Represented Nigerian investment app Bamboo Inc. in a US$15M Series A fundraising round co-led by Greycroft and Tiger Global.
- Represented Bamboo Inc., a Nigerian investment app, in a US$15m Series A financing (2023).
- Represented NEA and Cortical Ventures as lead investors in a US$16m Series A financing of SeMi Technologies, an AI-focused technology company (2023).
- Represented NEA as lead investors in a US$16m Series A financing of Abcuro (2025).
- Represented NEA as lead investors in a US$16m Series A financing Bluefish (2025).
- Represented NEA as lead investors in a US$16m Series A financing of Fabric8 (2025).
- Represented AUA Private Equity in its investment in Gourmet Culinary Holdings (2022).
- Represented 829 Studios, a digital marketing services company, in a control investment by CVIC partners (2021).
- Represented Symphony AI in its acquisition of TeraRecon, an AI medical imagining company (2020).
Awards and Recognition
- Selected for Best Lawyers: Ones to Watch Mergers and Acquisitions Law (2024)
Affiliations
- Member, Boston Bar Association
Presentations and Publications
- Speaker, Boston Start Up Week (September 2023, 2024, 2025)
- Moderator, Female Founders & Funders Event co-hosted with Girls Into VC (May 2025)
- Moderator, Relationships and Raising: How Female & Non‑Binary Founders Can Leverage Networks for Fundraising (December 2024)
- Speaker, Female Founders and Funders Event (September 2024)
- Moderator, Fireside Chat at New York Tech Week, co-hosted with Redwood Collective (June 2024)
- Moderator, “Breaking Barriers and Sealing Deals: How Women Will Win in Venture Capital” (November 2022)
- Co-author, “Post-COVID M&A Transactions Guidebook,” Foley’s Coronavirus Resource Center: Back to Business (October 2020)
Female Founders & Funders: Women in Health Tech & Innovation
Start your day with the people shaping tomorrow’s healthcare innovations. Join Foley & Lardner, Silicon Valley Bank and CVS Health Ventures for a curated Female Founders & Funders Breakfast bringing together the builders, backers, and boundary pushers shaping the next wave of health tech and innovation.
Foley Represents NEA as a Lead Investor in $50M Funding Round for Fabric8Labs
Foley & Lardner LLP recently represented New Enterprise Associates, Inc. (NEA) as lead investor in the $50 million funding round for Fabric8Labs, the company pioneering electrochemical additive manufacturing.
You Need a Contract!: From Your First Customer to Your First Financing and all the Contracts in Between
Join Foley & Lardner LLP at Startup Boston Week 2025 to learn essential contracts for formation, funding, and scaling your startup.
Female Founders & Funders Breakfast
Are you a female or nonbinary founder looking to navigate the complex world of fundraising? We invite you to an exclusive panel discussion hosted by Foundess, Foley & Lardner, and Girls Into VC on how to approach fundraising and funding strategies.
Foley Represents NEA as Lead Investor in $200M Series C Round for Abcuro
Foley & Lardner LLP represented New Enterprise Associates (NEA) as the lead investor in the $200 million Series C financing for Abcuro, a clinical-stage biotechnology company.
Foley Represents Envisioning Partners as Investor in Series B Round for Phoenix Tailings
Foley & Lardner LLP represented Envisioning Partners as an investor in the $33 million Series B extension funding for Phoenix Tailings, a Burlington, Massachusetts, developer of rare earths from mining waste, for a total funding of $76 million.